Editorial: Strategies in overcoming the chemoresistance in colorectal cancer
Status PubMed-not-MEDLINE Language English Country Switzerland Media electronic-ecollection
Document type Editorial
PubMed
37849807
PubMed Central
PMC10578867
DOI
10.3389/fonc.2023.1295204
Knihovny.cz E-resources
- Keywords
- adjuvant chemotherapy, chemoresistance, colorectal cancer, fruquintinib, platinum derivates, radiotherapy, traditional Chinese medicine,
- Publication type
- Editorial MeSH
Biomedical Centre Faculty of Medicine in Pilsen Charles University Pilsen Czechia
Institute of Biology and Medical Genetics 1st Faculty of Medicine Charles University Prague Czechia
Editorial on the Research TopicStrategies in overcoming the chemoresistance in colorectal cancer PubMed
See more in PubMed
Vodenkova S, Buchler T, Cervena K, Veskrnova V, Vodicka P, Vymetalkova V. 5-fluorouracil and other fluoropyrimidines in colorectal cancer: Past, present and future. Pharmacol Ther (2020) 206:107447. doi: 10.1016/j.pharmthera.2019.107447 PubMed DOI
Rejhová A, Opattová A, Čumová A, Slíva D, Vodička P. Natural compounds and combination therapy in colorectal cancer treatment. Eur J Med Chem (2018) 144:582–94. doi: 10.1016/j.ejmech.2017.12.039 PubMed DOI
Iyer KK, van Erp NP, Tauriello DVF, Verheul HMW, Poel D. Lost in translation: Revisiting the use of tyrosine kinase inhibitors in colorectal cancer. Cancer Treat Rev (2022) 110:102466. doi: 10.1016/j.ctrv.2022.102466 PubMed DOI
